Kate A. Raustad
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)
Publications by Year
Research Areas
Receptor Mechanisms and Signaling, Regulation of Appetite and Obesity, Adipose Tissue and Metabolism, Neuroscience and Neuropharmacology Research, Neuropeptides and Animal Physiology
Most-Cited Works
- → Discovery of MK-7725, A Potent, Selective Bombesin Receptor Subtype-3 Agonist for the Treatment of Obesity(2012)62 cited
- → Antiobesity Effect of MK-5046, a Novel Bombesin Receptor Subtype-3 Agonist(2010)49 cited
- → Body temperature as a mouse pharmacodynamic response to bombesin receptor subtype-3 agonists and other potential obesity treatments(2010)30 cited